The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
The Effect Of Statin And Colchicine On Pericoronary Adipose Tissue Inflammation And Coronary Artery Plaque Progression: Insights From Cardiac Computed Tomography Using Pericoronary Adipose Tissue Attenuation And Radiomics
Funder
National Health and Medical Research Council
Funding Amount
$125,396.00
Summary
Coronary artery disease is the leading cause of death in Australia. Inflammation is a key driver of harmful build-up of cholesterol plaques in arteries. Currently it is unclear how to detect patients with high level of inflammation. We examine a new approach to detect coronary inflammation using CT coronary angiography (CTCA). We investigate how to utilise CTCA to guide targeted therapy with statin and colchicine in patients with residual inflammation to reduce risk of future heart attack.
Developing A Framework To Evaluate Low Value Prescribing In The Australian Health Care Setting
Funder
National Health and Medical Research Council
Funding Amount
$124,608.00
Summary
The aim of this project is to develop a framework to evaluate the quality of prescribing in Australia using routinely collected administrative health data. Given growing concerns regarding the quality of prescribing of psychotropic medicines and opioids, these medicines will be e focus of the study. Patterns, quality markers and health and financial consequences of poor prescribing will be assessed.
Polypharmacy In The Heart Failure Patient: Are All Prescribed Drug Classes Required?
Funder
National Health and Medical Research Council
Funding Amount
$134,110.00
Summary
This project investigates the issue of polypharmacy is heart failure. Polypharmacy is the use of four or more prescription medications, and heart failure patients take six on average. This project investigates the evidence for safe withdrawal of medications failure that have not been shown to prolong life in heart, doctor and patient attitudes to withdrawing medications, and then runs a series of three clinical trials, each withdrawing a different medication in heart failure patients and closely ....This project investigates the issue of polypharmacy is heart failure. Polypharmacy is the use of four or more prescription medications, and heart failure patients take six on average. This project investigates the evidence for safe withdrawal of medications failure that have not been shown to prolong life in heart, doctor and patient attitudes to withdrawing medications, and then runs a series of three clinical trials, each withdrawing a different medication in heart failure patients and closely monitors the effects.Read moreRead less
Early Detection Of Melanoma Metastases Using MicroRNA As Novel Biomarkers
Funder
National Health and Medical Research Council
Funding Amount
$109,363.00
Summary
The use of a minimally invasive blood test to measure the circulating levels of melanoma-specific miRNAs may provide a rapid assessment for clinical management of the disease during dissemination of the tumour. This work has the potential to provide new prognostic markers for melanoma as well as to identify new gene targets for the design of rational therapies to treat this disease.
Mechanisms Of Retinal Functional Hyperaemia In Humans With And Without Type 1 Diabetes
Funder
National Health and Medical Research Council
Funding Amount
$117,526.00
Summary
Fenofibrate has been shown to reduce the progression of diabetic retinopathy (DR) in patients with type 2 diabetes by up to 40%, however the mechanisms behind this result are poorly understood. This research will investigate measures of local and systemic endothelial dysfunction and levels of lipids and lipoproteins to determine how fenofibrate affects the progression of DR in patients with type 2 diabetes and in doing so form the basis of further basic and clinical research.
The Importance Of RUNX3 In Preventing Gastrointestinal Diseases And Tumour Metastasis
Funder
National Health and Medical Research Council
Funding Amount
$113,322.00
Summary
Stomach cancer is the second leading cause of cancer-related deaths. It is estimated that in 2010, more than 1 million people will die of stomach cancer with an increase of 19%. Studies have revealed that RUNX3 has the ability to suppress the growth of stomach cancer. However the role of RUNX3 in preventing metastasis is yet unknown. Therefore, an understanding of the factors that govern metastasis will inform the design of effective therapies to prevent mortality which is high for this disease.